Time Controlled Adaptive Ventilation/Airway Pressure Release Ventilation Can be Used Effectively in Patients With or at High Risk of Acute Respiratory Distress Syndrome "Time is the Soul of the World" Pythagoras.

Competing Interests: Dr. Habashi disclosed that he has patents in the field of mechanical ventilation and airway pressure release ventilation. Dr. Bates’ institution received funding from the National Institutes of Health (NIH) (HL142702); he received funding from Oscillavent, Respiratory Sciences, and Johnson & Johnson; he disclosed that he is co-inventor on patents (US7945303 B2, WO2015127377 A1, and 20160007882 A1) and that he has a patent pending (PCT/US21/24537). Dr. Bates and Nieman received support for article research from the NIH. Dr. Nieman’s institution received funding from Drager Medical; he received support for article research from the Congressionally Directed Medical Research Programs Department of Defense. The remaining authors have disclosed that they do not have any potential conflicts of interest.